Jonathan Isaacsohn - 17 Aug 2022 Form 4/A - Amendment Insider Report for vTv Therapeutics Inc. (VTVT)

Role
Director
Signature
/s/ Paul Sekhri, as Attorney-in-Fact
Issuer symbol
VTVT
Transactions as of
17 Aug 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
21 Jun 2023, 16:27:02 UTC
Date Of Original Report
18 Aug 2022
Previous filing
18 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VTVT Director stock option (right to buy) 0 17 Aug 2022 Class A Common Stock 0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the reported option award and holdings of the Reporting Person as of August 17, 2022. The option award was made in error as the Reporting Person has elected not to receive equity awards in connection with his service as a director.